These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1307635)

  • 41. M. Keller on the Conversion of Benzoic into Hippuric Acid.
    Keller W
    Prov Med J Retrosp Med Sci; 1842 Jul; 4(92):256-7. PubMed ID: 21373397
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical significance of benzoate-metabolizing capacity in patients with chronic liver disease: pharmacokinetic analysis.
    Yamada S; Yamamoto T; Suou T; Fujii T; Takayama M; Amisaki T; Tabuchi F; Kobayashi J; Hasegawa M; Hoshino U
    Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):53-62. PubMed ID: 1518961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
    Cho HY; Moon JD; Lee YB
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
    Chalon SA; Desager JP; Desante KA; Frye RF; Witcher J; Long AJ; Sauer JM; Golnez JL; Smith BP; Thomasson HR; Horsmans Y
    Clin Pharmacol Ther; 2003 Mar; 73(3):178-91. PubMed ID: 12621383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical usefulness of benzoate tolerance test in patients with liver cirrhosis].
    Takayama M; Yamada S
    Rinsho Byori; 1992 Dec; 40(12):1303-6. PubMed ID: 1307635
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.